Replies to post #763219 on NorthWest Biotherapeutics Inc (NWBO)

[jdheart101]

Cause you did 

[The Danish Dude]

Cool. Nothing to say, then.

What I said first time around when I dissected your crap was enough.

What I had to say this time around, went straight to the company.

No you are every bit your own, with a dedicated biased perspective of promoting a narrative that omits and misinterprets to market makers delight, fortunate enough in time to give them a motive and justification of their manipulation, which you obviously like not to be mentioned in your articles, especially not the “going to discovery” part.

Perhaps Feuerstein will agree to share some fame, when MMs in the future are gonna point to the information upon which they want people to believe they manipu….. sorry traded?

I hope my research into your abilities as an … is it analyst? … is more on target. Which I leave up to the company to decide.

Thanks to mugs57 for heads up 👍🏻

See no reason to delve further into the pitiful “research” of the new hit piece.

Once was enough

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530865

Company has issued communication. They've reported in the 10K exactly why they issue shares like this.
- Galzus Research

Oh you DO read SEC filings? Wow that comes as a surprise.

SHORT AND DISTORT
Joshua Mitts Paper

https://www.law.berkeley.edu/wp-content/uploads/2019/05/Mitts-Short-and-Distort-_111.pdf

In this paper, I show how pseudonymity undermines reputational accountability in financial markets. I examine 2,900 attack articles against mid- and large-cap firms published on a website, Seeking Alpha, and show that pseudonymous ones are followed by stock-price declines and sharp reversals, leading to over $20.1 billion in mispricing. I employ propensity-score matching between pseudonymous and real-name attacks and use a triple-difference design to show abnormal put options trading with publication. On the day of publication, the open interest and volume of put options written on the target of a pseudonymous article are higher than call options.

[tucsonchas]

Or just working together with a wink and a nod.